ASX · ALA.AX
Arovella Therapeutics Limited
A$0.05A$0.00 (0.0%)
Arovella Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 47.0% below the high.
Loading market information…
ASX · ACW.AX · AUD
Stock price, earnings
Quote as of Oct 30, 2026, 04:44 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
Actinogen Medical Limited’s quoted price sits in the lower half of its reported 52-week range, 43.06% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Actinogen Medical Limited’s next earnings report is currently expected on Feb 24, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Actinogen Medical Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Actinogen Medical Limited is an Australian biotechnology company dedicated to developing treatments for neurological and neuropsychiatric disorders linked to imbalanced brain cortisol levels. Their lead product, Xanamem, an inhibitor of the 11ß-HSD1 enzyme, is currently in Phase 2 clinical trials. This compound has demonstrated target engagement within the central nervous system and is being investigated for its potential in conditions such as Alzheimer's disease, depression with cognitive impairment, and the anxiety, sleep, and behavioral issues associated with fragile X syndrome. Founded in 1999, the company was formerly known as Actinogen Limited, adopting its current name in November 2015, and is headquartered in Sydney, Australia.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Jul 31, 2023 |
| -A$0.00 |
| A$1.14M-75.43% vs estimate |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$0.05A$0.00 (0.0%)
Arovella Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 47.0% below the high.
A$0.26A$0.00 (0.0%)
Alterity Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 66.88% below the high.
